Nano-hydroxyapatite and Ozone - Effect on Approximal Initial Caries

October 30, 2019 updated by: Katarzyna Grocholewicz, Pomeranian Medical University Szczecin

Influence of Nano-hydroxyapatite and Ozone on Approximal Initial Caries

Objectives: to assess the efficiency of three methods of enamel remineralization on initial approximal caries: 1. a nano-hydroxyapatite gel, 2. gaseous ozone therapy 3. combination of a nano-hydroxyapatite gel and ozone.

Materials and Methods: Patients (n=92, age 20-30y) with initial approximal enamel lesions on premolar and molar teeth (n=546) randomly allocated to three groups subjected to a 6-months treatment: Group I: domestic nano-hydroxyapatite remineralizing gel, group II: in-office ozone therapy, group III: both remineralizing gel and ozone therapy. Caries lesions assessed on bitewing radiographs at baseline, after 1 year and after 2 years.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

92

Phase

  • Phase 2
  • Phase 3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

-initial approximal enamel lesions on premolar and molar teeth

Exclusion Criteria:

  • distal surface of the last tooth in arch, overlapping teeth
  • fillings on approximal surfaces of teeth of interest
  • ongoing orthodontic therapy with braces or other appliances

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: domestic nanohydroxyapatite gel ApaCare & Repair
6-months treatment, caries lesions were assessed on bitewing radiographs at baseline, after 1 year and after 2 years
Initial cariuos lesions were treated.
Other Names:
  • OzonyTron
Experimental: in-office ozone therapy OzonyTron
6-months treatment, caries lesions were assessed on bitewing radiographs at baseline, after 1 year and after 2 years
Initial cariuos lesions were treated.
Other Names:
  • OzonyTron
Experimental: both remineralizing gel and ozone therapy
6-months treatment, caries lesions were assessed on bitewing radiographs at baseline, after 1 year and after 2 years
Initial cariuos lesions were treated.
Other Names:
  • OzonyTron

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Remineralizing effect
Time Frame: baseline
Caries lesions were assessed on bitewing radiographs
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Remineralizing effect - follow-up
Time Frame: after 1 year and after 2 years
Caries lesions were assessed on bitewing radiographs
after 1 year and after 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2012

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

October 21, 2019

First Submitted That Met QC Criteria

October 30, 2019

First Posted (Actual)

October 31, 2019

Study Record Updates

Last Update Posted (Actual)

October 31, 2019

Last Update Submitted That Met QC Criteria

October 30, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • KB-0012/102/11

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caries,Dental

Clinical Trials on ApaCare & Repair

Subscribe